Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Phythalabs in Washington state had similar future potential revenue model calculated where "Testing" is mandatory.
And what happened later, State allowed 10-15 more labs and the competition started cutting into each other's margin.
You are assuming all the business is going to go to SGBY and that won't be true on Oct 1st.
guess how much of those 177 mil is already diluted and available as part of the float.
Subsequent to June 30, 2016, the Company issued 177,507,121
So CEO has set the expectation right, they won't be making a lot money until 2018. Who will pay for all those 18 labs acquisition.
Oh, I forgot, there are Longs, who are ready to hold this high above while CEO dilutes the remainder 2.2 bil shares...
good luck holding long
Authorized Shares: 3,000,000,000
Outstanding Shares as of September 6: 780,048,869
Float as of September 6: 454,947,868
Looks like you are already sitting on the side ....
Yeah, there is clarity, but reality also sinks in that there revenue is not as much it as hyped to be. I am not denying they will have increased revenues , but not to the level it is hyped here.
3 months with 3 labs on , and the revenue is just few hundred k.
i hope it gets soon, cause i see this going back to 0.008's from where it all started.... by tomorrow
Please do your DD and call up Gary , ORELAP administrator..
You are not accounting for the competition. Oregon is a lot smaller mkt than CA. Their three running labs are in Oregon. The one is CA is not yet acquired.
You are just creating hype and pumping with future that is 3-5 yrs from now. The question is what is the real AS and has the company being diluting their investors while making all the news
There is nothing like true longs. Longs are the ones that will ask others to hold bags while they cash out.
You can be long with your foresight. I am not denying future is bright after 5 years from now. But at this point , it is way hyped for the kind of revenue and business model they have in place.
It took 8 yrs for SteepHill labs in CA to make 1.5 mil, you think SGBY is better positioned than a lab running from more than 8 yrs.
Please be realistic.
Oct 1st they will have more than 20 labs certified, and by November another 20. They have received more than 40 applications. So all this hype and monopoly is not going to last for more than a month or two.
You think they will make more than mil in 2 months...
This POS has been pumped too much. The reality is they will end up making not more than 2 mil in whole of 2017 and right now the mcap of 20 mil just does not justify.
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
On September 9, 2016, the Company's Board of Directors voted to decrease the annual salary for Chad Ruby, the Company's Chief Operating Officer, from $115,000 to $-0- for the remainder of the year ended December 31, 2016.
Chad Ruby has been filing form 4's to sell all her shares at 0.16's
something must be wrong, otherwise why would someone sell when they can get $2 in next 2 months..
Can you explain all the form 4's by COO and VP's selling at 0.16's
It is hard to believe that "Dispensaries" which are the retail outlets of this sector are not profitable even now (looks at KAY#) and the testing lab will suddenly make a lot more revenue then them.
The testing is only done on a sample of the raw material or finished product and not all of it. There will be a lot less testing than what is being projected here.
CEO has nothing but let the MM's / pumpers take over the hype and is behind the scene diluting the longs.
The longs too are fake ones and are actually trading and creating naive bag holders who seem to rush to this stock thinking they have missed the boat.
Look what happened to those who bought at 0.03, down more than 20% today.
If that was the case, it wouldn't have fallen 20%. There is a possibility that Oregon will not enforce testing from Oct 1st as most of the labs are not ready.
There is a strong opposition by the Dispensaries etc. to continue the status quo until more labs are certified to avoid cutting into their profits which is not much.
But with the legislation comes more and more testing labs. SGBY is not the only one that will jump on this opportunity. So all the hype related to the numbers is all speculation.
It is going to cost to set up labs, equipment's and hire technicians, just like any other business, lab is not going be profitable on 1st or 2nd year of opening, and may take 3+yrs to breakeven on investments.
The state might just decide to continue basic testing of THC levels on the raw material or edibles and not go whole 9 yrds.
I think today's price correction is the starting point and if any such announcement is made by state then SYGB will loose significant potential /speculated revenue in the short term.
The current mcap of 21 mil does not justify the stated revenue of less than 300k.
You are not accounting for the fact that Oregon can relax their policy until many more labs get certified. You think these 3 are the only ones who will get all the orders.
Based on the pressure that has been put on the industry, there they can always change the deadline as it is right now there is no such testing.
they might still enforce some kind of basic testing.
The numbers you are speculating is not what the real revenues are . In last 6 months all they could get is couple hundred thousand in revenue, not even close to half mil. Q2 results will set the expectation right.
Yesterday's article about state not being able to meet the deadline is an eyeopener.
This will not go beyond 0.03 until Q2 is out and Oct 1st annoucements are made.
Will it drop if any of those are not in its favor is a risk you are living with holding this stock long
It won't impact Abattis, they have no proven sales, too many failure history with all the ventures they undertook, NPN product launches, Hemp H2O, Vitagum, Biocell, Biocube and even Phythalabs, and not to forget the famous CSL that hasn't come through.
I think all these LP's when they try to acquire a company, they will go after proven ones. SPR## and ORG##, TWD or AU### all are established. Even if they venture with ATTBF, they will just license the technology or buy the specific unit and get rid of all the fat (RD)
The alternative you are suggesting or hinting SG.. is not making even 3% of TRTC's revenue of 2016. The OS is a lot more than TRTC's and without financials, only insiders knows how much dilution is going on.
Based on today's price action, that ticker of your's is going to go down to .005 where it all started.
good luck.
you did good for yourself.
it was clearly overbought, and 2 weeks history chart will show that it has corrected itself 50% or so after going up consecutively for three days
I just told you, this is way overbought, has to test 0.014 before it can go up any further. There is limited information available about this company. has to go down
This is going to retest 0.020 and .014 support levels before going any further up
There is no pre market volume, its a trap. This is going back to 0.014.
Abattis is the worst company in Canadian sector.
Look at SGB#, they started with consulting, and then a lab and now they have 3 labs and 2 more that are going to join soon.
Abattis temporarily shutdown Phythalabs instead of going with a Franchise model in Oregon, Colorado. They opened it in a location where they could not capture the market.
Even the Northern wines CSL has not come through and their final inspection was announced in june.
CEO/Directors etc are leaving this POS every couple of months.
The company folks are not reachable, no one is picking up phones.
Looks like they are going for Chapter 11.
I think they lost their focus trying to do everything, Biocell, Biocube, Pythalabs, Phythos, Vitagum, CSL, Hemp H2O, no tangible sales, only directors joining and leaving the company.
The RD benefiting from all this by loaning his money from his own Crimon group.
If anyone wants to file a lawsuit, count me in.
Based on that the revenue will be between 700k to 1 mil, thats too less compared to TRT# where it is projected to be 27mil.
The OS is similar in both. SGBY has far more AS than the other.
The labs cannot produce revenue like a retails does, period.
We will see on monday/tuesday. Mark this post
It will be testing 0.014 on monday and 0.011 by tuesday. I will stabilize between 0.011 and 0.020 in coming weeks until the news is out for Q2 and other pending acquisitions etc.
in the long run I do see it as 5 to 10 bagger from 0.020 just before election.
then depending on the outcome another 5 to 10 bagger and then it will drop back to 0.020
monday it will go down and test 0.014 & may be 0.011 support levels
Agreed, as mentioned earlier, the revenue/profits are not much in testing.
Pythalabs had 10% mkt shared of Washington state, still could not survive the cost of operations.
Based on the 10Q it is clear their revenue is not going to be more 75k/Q and the cost of operations is going to be way higher than that.
The mcap of 10 mil is way higher for a company who revenue is not going to be more than few hundred thousand dollars and is having a burden of convertible notes.
Every acquisition of labs is going to add to the cost and more than it would to revenue.
Also based on technical reading, it is overbought.
Check last 10 days of it, you will realize that it is bound to retrack at some point.
You are right, but this will definitely retrack. The stock is overbought.
There two things that's bothering me.
a> Their filing is delayed.
b> Based on previous 10Q, the revenue is not enough from the labs. This company reminds me of Phythalabs that went down under in Washington state. The revenue from testing is not significant.
When is the S-3 they filed coming effective. They will dilute the existing shareholders to get $30.00 mil which they just filed on Sep 1st.
Please provide list of others that have risen 1000% in 90 days
Check any other ticker, since 2014 run, all have increased OS/AS in billions and have not increased the assets as much.
TRTC on other hand has increased the revenue 10 folds and increased assets 10 folds. The potential of revenue growth is 5-10 folds in next 2 yrs.
I think you missed your boat second time waiting for 0.22..
200 mil are in escrow. The float is 339 mil and will go max to 450-500 mil next year.
this will test high from the last run in by next week.
There is logic in OTC or for that matter in any market. Stocks are driven by future potential. Nobody can explain 2B of GWP# or valuation of Amazon or Tesla or any company.
It is all driven by what market fills as future potential is. The mcap has no meaning here. there is only 600-700mil in OS after Sept 26th and float will be around 400-500 mil. The value of $1 is still ok as their expected revenue in 2017 is approx 75 mil.
AS has no meaning, even if the OS is 700 mil, 200 of it is locked in escrow for Blum. So technically the Float is just somewhere around 500 mil.
I think you didn't expect this curve ball today and missed your opp. again to get in mid 20's.
Agreed, even insiders are not selling below 0.30's. The form 4 shows 10000 shares sold at 0.32s.
I think 0.30 is now the new 0.08